Relationship Between Platelet and Urinary 8‐Iso‐PGF2α Levels in Subjects With Different Degrees of NOX2 Regulation

Abstract

BackgroundUrinary 8‐iso‐PGF2α, a marker of oxidative stress, is influenced by the activation of NOX2. It is unclear if platelets 8‐iso‐PGF2α contribute to urinary 8‐iso‐PGF2α.Methods and ResultsIn a cross‐sectional study, platelet, urinary, and serum 8‐iso‐PGF2α were determined in subjects with downregulation (X‐linked chronic granulomatous disease [X‐CGD], n=25) and upregulation (type II diabetic patients [T2D], n=121) of NOX2 and 153 controls matched for sex and age. In diabetic patients (n=18), the above variables were repeated before and after 7 days treatment with 100 mg/day aspirin or 100 mg/day aspirin plus 40 mg/day atorvastatin. In vitro study was performed to see the contribution of blood cells to serum 8‐iso‐PGF2α. Compared with controls, X‐CGD patients had lower platelet, serum, and urinary 8‐iso‐PGF2α values; conversely, diabetic patients had higher values of 8‐iso‐PGF2α compared with controls. Urinary 8‐iso‐PGF2α significantly correlated with both platelet and serum 8‐iso‐PGF2α in the 2 cohorts. A parallel increase of platelet, serum, and urinary 8‐iso‐PGF2α by aspirin and a parallel decrease by aspirin plus atorvastatin were detected in the interventional study. In vitro study demonstrated that platelets contribute to 37% of serum 8‐iso‐PGF2α and that only 13% of it is of extravascular origin.ConclusionsThe study suggests that NOX2 contributes to the formation of 8‐iso‐PGF2α in both platelets and urine. The direct correlation between platelet and urinary 8‐iso‐PGF2α suggests that, at least partly, urinary 8‐iso‐PGF2α reflects platelet 8‐iso‐PGF2α production. Analysis of serum 8‐iso‐PGF2α may represent a novel tool to investigate the production of 8‐iso‐PGF2α by blood cells including platelets.Clinical Trial RegistrationURL: ClinicalTrials.gov. Unique Identifier: NCT01250340.

Different Degrees of NADPH Oxidase 2 Regulation and In Vivo Platelet Activation: Lesson From Chronic Granulomatous Disease

“…This finding was corroborated by analysis of in vivo platelet activation in obese subjects who, conversely, disclosed NOx2 upregulation coincidentally with a significant increase of both sCD40L and sP‐selectin. This is consistent with previous studies showing upregulation of NOx2 in patients with atherosclerotic risk factors such as those with hypercholesterolemia or diabetes …”

Oxidative stress in patients affected by primary aldosteronism

“…As previously shown by Carnevale et al [42], patients affected by diabetes mellitus, which is a model of high risk to development of cardiovascular complications, show higher levels of serum Nox2-dp and urinary, platelet and serum isoprostanes, with respect to healthy individuals and sNox2-dp (pg/ml) patients with hereditary deficiency of NOX2, as X-linked chronic granulomatous disease (X-CGD). So, as shown in the diabetic patients, in overall hypertensive patients, we have found a significant correlation between serum Nox2dp and urinary isoprostanes; moreover, in primary aldosteronism patients, we also found a significant correlation between serum Nox2-dp with plasma aldosterone levels and 24-h urinary excretion of aldosterone, and between plasma aldosterone and urinary isoprostanes.…”

Moderate physical training attenuates perinatal low-protein-induced spleen lymphocyte apoptosis in endotoxemic adult offspring rats

“…Serum was collected after a period of 30 min to allow coagulation followed by a 300×g centrifugation, 10 min (Beckman Coulter, Inc., Brea, USA) [25]. Serum samples were kept at −20 °C.…”